Department of Genetics and Cell Biology, University of Minnesota, Minneapolis, USA
Research Article
Antiestrogen Treatment for Androgen-Insensitive or Castration-Resistant Prostate Cancer, Identification of Estrogen Stem Cells, and Estrogen Receptors
Author(s): Akhouri A Sinha*
Objective: A variety of treatments (such as bilateral castration, chemical castration, adrenalectomy and
hypophysectomy) have not cured adenocarcinoma of Prostate Cancer (PC). We hypothesize that sub type (s) can
exist resulting in the failures of the above treatments.After Androgen Deprivation Therapy (ADT), PC emerges as
androgen-insensitive or Castration-Resistant Prostate Cancer (CRPC).Our study is designed to identify a sub type
of PC.
Materials and Methods: DES (diethylstilbestrol) treated and untreated prostate biopsy specimens were utilized to
identify two sub-types, androgen-sensitive and androgen-insensitive, tumours. Additional studies, such as localization
of isotopic estrogen and estrogen antibodies, were designed to further define the sub types of PC.
Results: Localization of isotopic es.. View more»